# Abivax SA (ABVX)

Abivax SA (ABVX) is experiencing significant social media buzz around potential M&A activity and upcoming ECCO [----] conference data, with investors closely watching for positive developments and potential price surges.

### About Abivax SA
Abivax SA is a clinical-stage biotechnology company focused on developing novel small molecule drugs for inflammatory and fibrotic diseases.  
Abivax SA uses the ticker $ABVX for trading. Listed in the [Stocks](/list/stocks) category.

### Insights
- Abivax SA (ABVX) market dominance near a 52-week high at [-------].
- Abivax SA (ABVX) sentiment is up 16.92% from the previous week.
- Abivax SA (ABVX) creators is up 13.08% from the previous week.
- Abivax SA (ABVX) engagements is up 58.42% from the previous week.
- Abivax SA (ABVX) mentions is up 30.13% from the previous week.
- Abivax SA (ABVX) posts created is up 165.35% from the previous week.
- Abivax SA Price hit a 52-Week high of $125.60 for the hour
- Abivax SA Price hit an all time of $125.60 for the hour

### Price: $125
![Price Line Chart](https://lunarcrush.com/gi/w:600/t:abivax-sa/c:line/m:close/iv:1d.svg)  
[Price 24-Hour Time-Series Raw Data](/topic/abivax-sa/time-series/close.tsv)  
The stock price is likely reacting positively to strong clinical trial results and ongoing M&A speculation, indicating investor confidence in the drug's potential and a possible acquisition. Recent social media posts echo this sentiment, with many discussing potential buyouts and the drug's efficacy.  

24-Hour: 0.79%
7-Day: 5.32%
30-Day: 6.74%

1-Year High: $145.30 on 2025-12-24  
1-Year Low: $6 on 2025-06-20  
  
  
### AltRank: [---]
![AltRank Line Chart](https://lunarcrush.com/gi/w:600/t:abivax-sa/c:line/m:alt_rank/iv:1d.svg)  
[AltRank 24-Hour Time-Series Raw Data](/topic/abivax-sa/time-series/alt_rank.tsv)  
Abivax SA (ABVX) is currently AltRank #554 based on combined combined social and market metrics
Daily Average: [---]  
[--] Week: [---] +42  
1-Year High: [---] on 2026-02-09  
1-Year Low: [--] on 2026-01-25  
  
  
### Galaxy Score: [-----]
![Galaxy Score Line Chart](https://lunarcrush.com/gi/w:600/t:abivax-sa/c:line/m:galaxy_score/iv:1d.svg)  
[Galaxy Score 24-Hour Time-Series Raw Data](/topic/abivax-sa/time-series/galaxy_score.tsv)  
Current Value: [-----]  
Daily Average: [--]  
[--] Week: [--] +2  
1-Year High: [--] on 2026-01-26  
1-Year Low: [--] on 2026-01-24  
  
  
### Engagements: [------] (24h)
![Engagements Line Chart](https://lunarcrush.com/gi/w:600/t:abivax-sa/c:line/m:interactions/iv:1d.svg)  
[Engagements 24-Hour Time-Series Raw Data](/topic/abivax-sa/time-series/interactions.tsv)  
Current Value: [------]  
Daily Average: [------]  
[--] Week: [-------] +58%  
[--] Month: [---------] -61%  
[--] Months: [----------] +226%  
[--] Year: [----------] +2,779%  
1-Year High: [---------] on 2025-07-23  
1-Year Low: [--] on 2025-05-10  

Engagements by network (24h):
X: [------]
Reddit: [--]
News: [--]
YouTube: [--]
TikTok: [--]

  
  
### Mentions: [---] (24h)
![Mentions Line Chart](https://lunarcrush.com/gi/w:600/t:abivax-sa/c:line/m:posts_active/iv:1d.svg)  
[Mentions 24-Hour Time-Series Raw Data](/topic/abivax-sa/time-series/posts_active.tsv)  
Current Value: [---]  
Daily Average: [---]  
[--] Week: [-----] +30%  
1-Year High: [-----] on 2025-07-24  
1-Year Low: [--] on 2025-05-10  

Mentions by network (24h):
X: [---]
Reddit: [--]
News: [--]
YouTube: [--]
TikTok: [--]

  
  
### Creators: [---] (24h)
![Creators Line Chart](https://lunarcrush.com/gi/w:600/t:abivax-sa/c:line/m:contributors_active/iv:1d.svg)  
[Creators 24-Hour Time-Series Raw Data](/topic/abivax-sa/time-series/contributors_active.tsv)  
[---] unique social accounts have posts mentioning Abivax SA (ABVX) in the last [--] hours which is down 26% from [---] in the previous [--] hours
Daily Average: [---]  
[--] Week: [---] +13%  
1-Year High: [---] on 2025-07-24  
1-Year Low: [--] on 2025-05-10  

The most influential creators that mention Abivax SA in the last [--] hours

| Creator                                              | Rank | Followers | Posts | Engagements |
| -------                                              | ---- | --------- | ----- | ----------- |
| [@Taintslapp12283](/creator/twitter/Taintslapp12283) | [--]    | [---]       | [--]     | [-----]       |
| [@tradingsssss](/creator/twitter/tradingsssss)       | [--]    | [-----]     | [--]     | [-----]       |
| [@DSAkdag](/creator/twitter/DSAkdag)                 | [--]    | [------]    | [--]     | [-----]       |
| [@MACROVET888](/creator/twitter/MACROVET888)         | [--]    | [---]       | [--]     | [-----]       |
| [@seedy19tron](/creator/twitter/seedy19tron)         | [--]    | [------]    | [--]    | [-----]       |
| [@A_May_MD](/creator/twitter/A_May_MD)               | [--]    | [------]    | [--]     | [---]         |
| [@Andre_AGTC](/creator/twitter/Andre_AGTC)           | [--]    | [-----]     | [--]     | [---]         |
| [@RNAiAnalyst](/creator/twitter/RNAiAnalyst)         | [--]    | [------]    | [--]     | [---]         |
| [@LaminarRed](/creator/twitter/LaminarRed)           | [--]    | [---]       | [--]     | [---]         |
| [@SizeInvestor](/creator/twitter/SizeInvestor)       | [--]   | [--]         | [--]     | [---]         |

[View More](/list/creators/abivax-sa/100)
  
  
### Sentiment: 73%
![Sentiment Line Chart](https://lunarcrush.com/gi/w:600/t:abivax-sa/c:line/m:sentiment/iv:1d.svg)  
[Sentiment 24-Hour Time-Series Raw Data](/topic/abivax-sa/time-series/sentiment.tsv)  
Current Value: 73%  
Daily Average: 84%  
[--] Week: 76% +11%  
[--] Month: 75% +5%  
[--] Months: 75% -13%  
[--] Year: 75% -25%  
1-Year High: 100% on 2025-02-26  
1-Year Low: 50% on 2025-02-20  

Most Supportive Themes:
- Positive Trial Results: (60%) Abivax announced positive results from its Phase 2b clinical trial for obefazimod in ulcerative colitis patients. The drug demonstrated significant efficacy and a favorable safety profile.
- Regulatory Progress: (30%) The company is actively engaging with regulatory authorities, including the FDA and EMA, to advance obefazimod towards market approval. Discussions are ongoing regarding the next steps in the regulatory process.
  
Most Critical Themes:
- Competition in IBD Market: (7.5%) The inflammatory bowel disease (IBD) market is highly competitive, with several established and emerging therapies. Abivax's obefazimod will face significant competition from existing treatments and new entrants.
- Manufacturing Scale-Up Challenges: (2.5%) Scaling up manufacturing for a new pharmaceutical product can present challenges. Ensuring consistent quality and sufficient supply to meet potential market demand will be crucial for Abivax.
  
  
  
### Social Dominance: 0.023%
![Social Dominance Line Chart](https://lunarcrush.com/gi/w:600/t:abivax-sa/c:line/m:social_dominance/iv:1d.svg)  
[Social Dominance 24-Hour Time-Series Raw Data](/topic/abivax-sa/time-series/social_dominance.tsv)  
Current Value: 0.023%  
Daily Average: 0.028%  
[--] Week: 0.025% -0.0087%  
[--] Month: 0.052% -0.047%  
[--] Months: 0.052% +0.0033%  
[--] Year: 0.052% +0.049%  
1-Year High: 0.184% on 2025-07-24  
1-Year Low: 0.0004% on 2025-05-10  
  
  
### Market Dominance: 0.011%
![Market Dominance Line Chart](https://lunarcrush.com/gi/w:600/t:abivax-sa/c:line/m:market_dominance/iv:1d.svg)  
[Market Dominance 24-Hour Time-Series Raw Data](/topic/abivax-sa/time-series/market_dominance.tsv)  
Current Value: 0.011%  
Daily Average: 0%  
1-Year High: 0.012% on 2026-02-15  
1-Year Low: 0.01% on 2026-02-02  
  
  
### Market Cap: $9,905,428,110
![Market Cap Line Chart](https://lunarcrush.com/gi/w:600/t:abivax-sa/c:line/m:market_cap/iv:1d.svg)  
[Market Cap 24-Hour Time-Series Raw Data](/topic/abivax-sa/time-series/market_cap.tsv)  
Current Value: $9,905,428,110  
Daily Average: $9,340,466,719  
[--] Week: $9,905,428,110 +6.60%  
[--] Month: $9,883,287,774 +7.60%  
1-Year High: $9,883,287,774 on 2026-02-13  
1-Year Low: $8,754,130,646 on 2026-02-05  

### Top Abivax SA Social Posts
Top posts by engagements in the last [--] hours

*Showing a maximum of [--] top social posts without a LunarCrush subscription.*

"$ABVX Here we go. https://discord.gg/HcjbrjnRea https://discord.gg/HcjbrjnRea"  
[X Link](https://x.com/TanuMondal29176/status/2023274038198751319) [@TanuMondal29176](/creator/x/TanuMondal29176) 2026-02-16T05:51Z [--] followers, [---] engagements


"Once again unpopular flight tracking is back. I do this purely for entertainment. $LLY Gulfstream G500 (N309EL) landed at 5:00 PM at Hanscom Field about [--] miles northwest of Boston. $ABVX https://twitter.com/i/web/status/2023206963845509491 https://twitter.com/i/web/status/2023206963845509491"  
[X Link](https://x.com/AnotherKoreanX/status/2023206963845509491) [@AnotherKoreanX](/creator/x/AnotherKoreanX) 2026-02-16T01:25Z [----] followers, [----] engagements


"$ABVX ⚠👀 Guys Don't miss the next move in a few hours. 💸➡ https://discord.gg/7PCTB3DeVt https://discord.gg/7PCTB3DeVt"  
[X Link](https://x.com/Anna_Fallonn/status/2023182544502706352) [@Anna_Fallonn](/creator/x/Anna_Fallonn) 2026-02-15T23:48Z [--] followers, [---] engagements


"Note to self. DO NOT BUY $ocul Tuesday PM Just buy more $nktr and $ABVX and steadily become richer over the next few months. May sneak a few shares $ocul tho"  
[X Link](https://x.com/Taintslapp12283/status/2023178645695848489) [@Taintslapp12283](/creator/x/Taintslapp12283) 2026-02-15T23:32Z [---] followers, [----] engagements

Limited data mode. Full metrics available with subscription: lunarcrush.com/pricing